Proteasomal non‐catalytic subunit PSMD2 as a potential therapeutic target in association with various clinicopathologic features in lung adenocarcinomas
Yasushi Matsuyama(Nagoya University), Takashi Takahashi(Aichi Cancer Center), Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), Chinatsu Arima(Nagoya University), Shuta Tomida(Okayama University), Ryoji Sugiyama(Nagoya University), Yasushi Yatabe(University Hospital Münster), Hidemi Goto(University of Oxford), Yasutomo Itoh(Nagoya University), Toshiyuki Takeuchi(Fujita Health University), Motoshi Suzuki(Fujita Health University)
Cited by 72
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Reduced Expression of the <b> <i>let-7</i> </b> MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival
|Cancer Research|2004|2.4k